Clinical Trials Directory

Trials / Completed

CompletedNCT06312618

Propofol Versus Dexmedetomidine Effect on Prevention Emergence Agitation

Efficacy of Propofol Versus Dexmedetomidine To Prevent Emergence Agitation After Sevoflurane Anesthesia In Children Undergoing Squint Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
3 Years – 7 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to compare Propofol versus Dexmedetomidine in children undergoing squint surgery. The main question it aims to answer is: • Which drug is more effective in preventing the appearance of Emergence Agitation in children after sevoflurane anesthesia in squint surgery, propofol or dexmedetomidine? Emergence agitation (EA) is a period of restlessness, agitation, inconsolable crying, disorientation, delusions, and hallucinations with impaired cognition and memory that commonly occurs in children undergoing ophthalmic surgery especially after Short acting volatile agents such as sevoflurane.

Conditions

Interventions

TypeNameDescription
DRUGPropofolAfter completion of the procedure and after regain muscle power sevoflurane administration will be ceased. children will be randomized to receive propofol 1mg/kg over 10 minutes (group 1) .
DRUGDexmedetomidineAfter completion of the procedure and after regain muscle power sevoflurane administration will be ceased. children will be randomized to receive dexmedetomidine 0.2 mcg/kg over 10 minutes (group 2).

Timeline

Start date
2024-03-15
Primary completion
2025-03-15
Completion
2025-03-15
First posted
2024-03-15
Last updated
2025-10-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06312618. Inclusion in this directory is not an endorsement.